For Pharmacists
For Technicians
For Students
Continuing Education
Policy/Advocacy Center
OSPA Members
Get Acrobat Reader
Get Acrobat Reader
to read pdf files
About the OSPAPharmacy CareersEventsSponsorsEndorsed ServicesContact Us

High Blood Pressure

report coverThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)

Reference Card (pdf, 2 pages)

Express Report (pdf, 54 pages)

This special version of the updated clinical practice guidelines for hypertension is written for the busy Primary Care Clinician. It focuses on practical applications of the new evidence, including a revised treatment algorithm, drug tables, and convenient references. Get this for the quick-study health worker who needs to keep abreast of standards of treatment and incorporate the latest evidence into daily practice. NIH Publication No. 03-5233.

Final Report (pdf, 47 pages)

The key messages of this report are these: in those older than age 50, systolic blood pressure (BP) of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP; beginning at 115/75 mm Hg, CVD risk doubles for each increment of 20/10 mm Hg; those who are normotensive at 55 years of age will have a 90% lifetime risk of developing hypertension; prehypertensive individuals (systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg) require health-promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions that are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg) for patients with diabetes and chronic kidney disease; for patients whose BP is more than 20 mm Hg above the systolic BP goal or more than 10 mm Hg above the diastolic BP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will be controlled only if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount.

Palm PDAJNC7 Program for your Palm OS and Pocket PC

This interactive guideline tool will assist the clinician in implementing the JNC 7 High Blood Pressure Guidelines at the point of care.

Activity Study | Drug Information | Treatment Guidelines | Immunization Delivery | Best Practices | Patient Safety | Oregon Law Shortcuts | State Health Plans | Third Party Insurance Info | MEDICARE Shortcuts | FDA Shortcuts | CDC Shortcuts | References & Journals | Associations | Services & Insurance

Antitrust and Privacy Policies
Updated March 7, 2008
Oregon State Pharmacy Association
29702-B SW Town Center Loop West / Wilsonville, OR 97070-6481

Oregon State Pharmacy Association

Governance

Member Benefits

Membership Form

Oregon Pharmacists Fund

Oregon Pharmacy Foundation

Board of Directors

Committees

Job Listings

Business Opportunities

Employment Stats

CE Programs &
Conferences

About Prescriptions

Patient Safety Info

Consumer Tips

Pharmacy Consulting Assoc.

Pharmacy Quality Commitment

PACE Alliance

Tri-State Distribution

Pharmacists Mutual Insurance

Pharmacy Marketing Group